{"entity":{"id":"nct03637816","kind":"trial","name":"Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer","aka":[],"tldr":"A phase 2/3 trial in lung cancer, run by M.D. Anderson Cancer Center, active but no longer recruiting.","summary":"Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer is a phase 2/3, randomised interventional study registered as NCT03637816 by M.D. Anderson Cancer Center, with a registry enrolment figure of 25 participants, started 2018-11-27 and due to reach its primary completion in 2026-12-31. Interventions recorded: Anamorelin Hydrochloride; Placebo; Questionnaire Administration. Conditions listed: Anorexia; Lung Non-Small Cell Carcinoma; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer. Primary outcome: To reach thematic saturation by qualitatively examining experiences related to anorexia at the baseline in advanced lung cancer patients with anorexia/cachexia receiving either oral Anamorelin 100 mg or placebo.. Lung eligibility wording from the registry: \"* Patients with a diagnosis of advanced non-small cell lung cancer\". Sites: United States. No results are recorded here; the registry entry is the source.","status":"active","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT03637816","url":"https://clinicaltrials.gov/study/NCT03637816"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03637816","phase":"2/3","setting":"Qualitative Study on Experiences Related to Anorexia and the Effects of Anamorelin and Placebo in Advanced Non-Small-Cell Lung Cancer Patients With Anorexia-Cachexia: A Preliminary Study","sponsor":"M.D. Anderson Cancer Center","enrolled":25,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03637816/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}